Deep Science Ventures
The Co-founder & CTO role focuses on leveraging artificial intelligence to drive predictable drug discovery and development within the pharmaceuticals industry. This position involves leading technical strategy and innovation to advance biotechnology solutions. The role is based in San Francisco, California, and is a full-time opportunity.
Headquarters
London, England, United Kingdom
Company Size
11-50 employees
Founded
2016
Deep Science Ventures is a venture creator that combines available scientific knowledge with founder-type scientists to build high-impact ventures. Its mission is to create a future where humanity and the planet thrive by turning cutting-edge science into scalable businesses. The organization operates at the intersection of science and entrepreneurship, translating scientific insights into venture-grade opportunities. By partnering scientists-turned-founders with rigorous venture creation, it aims to accelerate the development of transformative solutions.
How to solve the biotech bottleneck by funding ideas, not data
Jul 28, 2025
The Invisible Tsunami: Deep Science Ventures and Grantham Foundation sound alarm on toxicity crisis
Jul 18, 2025
Ironic Metals to Decarbonize Iron and Nickel Production with Anglo American and Deep Science Venture Backing
Dec 3, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Deep Science Ventures.
Deep Science Ventures didn’t post a salary, so this is our estimate from similar listings.
Who is Deep Science Ventures?
Oct 2, 2024
Co-Founder in Residence (Commercial), Reinventing Crop Nutrition & Weed Control
Deep Science Ventures